Endocure Ltd

Chronic conditions like cancer and endometriosis remain difficult to diagnose accurately due to the limitations of current imaging tools. Cancer is the most misdiagnosed of the 'big three' conditions, and 75% of endometriosis patients receive an incorrect diagnosis and are forced to undergo diagnostic surgery. While MRI and PET-CT often miss small findings, ultrasound is highly operator-dependent and inconsistent, leaving a critical gap in the early and reliable detection of diseases. Revealan™, our robotic ultrasound imaging platform, seamlessly integrates with any off-the-shelf ultrasound device to enable operator-agnostic, automated, AI-enabled, high-resolution 3D imaging. The robotic scan output is a series of standardized medical images with a density at least 10 times higher than that of an MRI. Our solution represents a transformative leap forward not only in the diagnosis and monitoring of various conditions but also in surgical planning. It stands alone as the premier solution offering comprehensive mapping to facilitate personalized treatment. Revealan™ is optimizing ultrasound for better patient outcomes.